Close Menu

Churning Out Some LSD

Jake Wintermute at Harvard University is on his way to using synthetic biology to make lysergic acid, a precursor to LSD, reports Ian Sample at the Guardian. Lysergic acid is also used to make certain medications. Wintermute gave an update on his work at the Synthetic Biology 5 meeting at Stanford University, and said that though he is not yet making lysergic acid, he has inserted two of the six needed biochemical pathways into yeast.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.

Nature News writes that scientists are trying to figure out how to name the new strains of SARS-CoV-2 that are emerging.

The New York Times reports that researchers are studying identical twins who had COVID-19 to understand the influence of genetics on disease severity.

In PNAS this week: epistasis affecting cystic fibrosis, Tiger rattlesnake genome gives venom insight, and more.